HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heng Zhao Selected Research

acriflavine chloride

1/2020Hypoxia-Inducible Factor 1α and 2α Have Beneficial Effects in Remote Ischemic Preconditioning Against Stroke by Modulating Inflammatory Responses in Aged Rats.
1/2018Hypoxia Inducible Factor 1α Plays a Key Role in Remote Ischemic Preconditioning Against Stroke by Modulating Inflammatory Responses in Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heng Zhao Research Topics

Disease

56Neoplasms (Cancer)
05/2024 - 09/2008
49Stroke (Strokes)
01/2021 - 05/2003
31Ischemia
01/2020 - 05/2003
20Lung Neoplasms (Lung Cancer)
01/2023 - 04/2012
20Infarction (Infarctions)
01/2020 - 05/2003
17Inflammation (Inflammations)
03/2024 - 12/2007
17Brain Ischemia (Cerebral Ischemia)
01/2019 - 08/2002
14Hypothermia
01/2014 - 05/2003
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 01/2013
13Brain Injuries (Brain Injury)
04/2020 - 03/2004
8Infections
06/2022 - 09/2008
7Adenocarcinoma
12/2022 - 08/2016
7Ischemic Stroke
06/2021 - 01/2008
7Esophageal Squamous Cell Carcinoma
01/2021 - 02/2013
6Adenocarcinoma of Lung
01/2021 - 02/2014
5Glioblastoma (Glioblastoma Multiforme)
10/2023 - 01/2018
5Thymoma (Thymic Carcinoma)
11/2015 - 07/2013
4Bites and Stings (Sting)
05/2024 - 01/2021
4Reperfusion Injury
03/2024 - 05/2009
4Brain Neoplasms (Brain Tumor)
01/2023 - 02/2015
4Glioma (Gliomas)
01/2023 - 11/2019
4Hypoxia (Hypoxemia)
01/2020 - 03/2011
4Carcinogenesis
10/2019 - 05/2014
4Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2019 - 06/2012
3Myopia
02/2024 - 11/2023
3Body Weight (Weight, Body)
12/2023 - 01/2018
3COVID-19
12/2022 - 12/2021
3Virus Diseases (Viral Diseases)
11/2022 - 03/2008
3Margins of Excision
11/2022 - 01/2021
3Breast Neoplasms (Breast Cancer)
01/2022 - 09/2008
3Neoplasm Metastasis (Metastasis)
04/2021 - 01/2014
3Neuroinflammatory Diseases
01/2021 - 01/2016
3Atherosclerosis
03/2020 - 01/2016
3Wounds and Injuries (Trauma)
01/2020 - 06/2012
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019 - 01/2013
3Lymphatic Metastasis
01/2019 - 10/2013
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018 - 08/2004
2Vascular Calcification
05/2024 - 01/2017
2Hemorrhage
02/2024 - 01/2018
2Hepatocellular Carcinoma (Hepatoma)
10/2023 - 05/2010

Drug/Important Bio-Agent (IBA)

26Proteins (Proteins, Gene)FDA Link
12/2023 - 05/2003
13Biomarkers (Surrogate Marker)IBA
12/2023 - 04/2012
10CytokinesIBA
09/2023 - 08/2005
9MicroRNAs (MicroRNA)IBA
05/2024 - 05/2014
8DNA (Deoxyribonucleic Acid)IBA
05/2024 - 01/2018
8Cytochromes c (Cytochrome c)IBA
09/2007 - 05/2003
7Reactive Oxygen Species (Oxygen Radicals)IBA
11/2022 - 03/2004
7CaspasesIBA
01/2021 - 05/2003
6InterferonsIBA
12/2022 - 05/2010
5EnzymesIBA
12/2023 - 01/2013
5RNA (Ribonucleic Acid)IBA
01/2023 - 01/2016
5Circulating Tumor DNAIBA
12/2022 - 01/2018
5VaccinesIBA
12/2022 - 01/2021
5Peptides (Polypeptides)IBA
11/2022 - 09/2008
5Caspase 3 (Caspase-3)IBA
11/2022 - 05/2003
5Messenger RNA (mRNA)IBA
01/2022 - 04/2012
5Neuroprotective AgentsIBA
01/2018 - 08/2007
5Free RadicalsIBA
04/2015 - 09/2006
4ErbB Receptors (EGF Receptor)IBA
12/2022 - 01/2013
4Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2022 - 01/2013
4Interleukin-6 (Interleukin 6)IBA
07/2022 - 01/2016
4Oxidoreductases (Dehydrogenase)IBA
10/2019 - 10/2012
4Interleukin-10 (Interleukin 10)IBA
01/2019 - 01/2014
4Polymethyl Methacrylate (Sol)IBA
06/2018 - 04/2015
4Adenosine Triphosphate (ATP)IBA
01/2016 - 05/2003
4Phosphotransferases (Kinase)IBA
09/2010 - 10/2005
3MethyltransferasesIBA
05/2024 - 11/2019
3Cisplatin (Platino)FDA LinkGeneric
12/2022 - 10/2017
3AntigensIBA
12/2022 - 04/2016
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 01/2009
3Long Noncoding RNAIBA
01/2020 - 01/2018
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2019 - 02/2013
3Interleukin-4 (Interleukin 4)IBA
01/2019 - 01/2016
3Carcinoembryonic AntigenIBA
01/2019 - 10/2013
3Tyrosine Kinase InhibitorsIBA
01/2019 - 01/2013
3TOR Serine-Threonine KinasesIBA
01/2018 - 12/2013
3Glucose (Dextrose)FDA LinkGeneric
01/2018 - 08/2004
3Interleukin-2 (IL2)IBA
01/2014 - 09/2008
3Glutamic Acid (Glutamate)FDA Link
04/2012 - 08/2004
3AntioxidantsIBA
03/2011 - 03/2004
3beta CateninIBA
05/2008 - 10/2005
3Glycogen Synthase Kinase 3 betaIBA
03/2008 - 10/2005
2pyrimidin-2-one beta-ribofuranosideIBA
05/2024 - 01/2021
2Retinaldehyde (Retinal)IBA
03/2024 - 01/2023
2Lactic Acid (Lactate)FDA LinkGeneric
03/2024 - 02/2013
2Indicators and Reagents (Reagents)IBA
12/2023 - 11/2019
2LipidsIBA
12/2023 - 01/2021

Therapy/Procedure

33Therapeutics
11/2023 - 05/2003
17Ischemic Postconditioning
06/2021 - 09/2006
7Drug Therapy (Chemotherapy)
09/2023 - 11/2018
5Immunotherapy
05/2024 - 01/2021
5Lymph Node Excision (Lymph Node Dissection)
03/2018 - 09/2012
5Thymectomy
11/2015 - 07/2013
4Segmental Mastectomy (Lumpectomy)
01/2023 - 03/2018
4Radiotherapy
01/2023 - 01/2021
4Adjuvant Chemotherapy
12/2022 - 09/2016
4Precision Medicine
01/2019 - 01/2018
3Adjuvant Radiotherapy
01/2023 - 01/2016
3Neoadjuvant Therapy
01/2019 - 09/2015
3Thoracotomy
01/2018 - 03/2013